This medicine should be given with caution to patients with epilepsy, severe cardiovascular disorders, liver disorders, glaucoma, urinary retention, prostatic enlargement, pyloroduodenal obstruction, asthma, bronchitis, bronchiectasis, thyrotoxicosis and severe hypertension.
Special care should be taken when using chlorphenamine maleate in children and the elderly as they are more prone to developing neurological anticholinergic effects.
Warning: May cause drowsiness. If affected do not drive or operate machinery. Avoid alcoholic drink.
If symptoms do not go away within 5 days talk to a pharmacist or doctor.
Although most antihistamines should be avoided by patients with porphyria, chlorpheniramine maleate has been used and is thought to be safe.